Chamber and committees

Testing for people who do not have COVID-19 symptoms was made available to everyone in Scotland on 26 April. Everyone can now access free lateral flow devices (LFD), for testing at home twice a week. To get a LFD test you can:

• order an LFD test kit pack online at GOV.UK for home delivery
• collect a test kit from your nearest COVID-19 test site , by applying the “pick up sites for test kits” filter on the site finder.

As announced at the launch of the universally accessible testing offer, we continue to explore other options for increasing accessibility of testing across Scotland including the option to collect LFD test kit from pharmacies. I expect to be in a position to confirm these arrangements shortly.

The Scottish Testing Programme is kept under constant review in line with the latest clinical and scientific advice.

The Scottish Government recognises the need to tackle our throw-away culture, which includes so-called ‘fast fashion’. For example, the Revolve Programme run by Zero Waste Scotland already seeks to raise awareness of the benefits of responsible consumption by promoting the environmental benefits of second-hand over new clothing purchases, as well as directing consumers to the network of over 100 certified stores: What is Revolve? | The first choice for second-hand shopping (zerowastescotland.org.uk) .

SEPA has identified that Textiles and Apparel Manufacture will be the subject of a forthcoming Sector Plan. This will set out how SEPA will regulate and engage with the industry to tackle and reduce the environmental impacts from the textile sector: Plans in development | Scottish Environment Protection Agency (SEPA) .

The Scottish Government is committed to bringing forward a Circular Economy Bill to advance Scotland's ambitions to promote an economy where materials remain in use for as long as possible, rather than being thrown away, and to establish a fund based on the success of the Saltire Tidal Energy Challenge Fund for innovation in tackling textile pollution and throw-away culture.

The Scottish Government remains committed to implementing the licensing of driven grouse shooting and is currently developing proposals for a full public and stakeholder consultation with the aim of bringing forward legislation during this parliamentary term.

The timing of the consultation will depend on the legislative programme for the Parliament, which will be set out in due course.

The Scottish Government is making good progress with the development of a Women’s Health Plan and aims to publish it within the first 100 days of this new government.

Ministers have not discussed the outcomes of the Island Communities Impact Assessment on HIAL’s Air Traffic Management 2030 Strategy with HIAL. Officials attended the HIAL Board meeting on 25 February 2021 where the issue was discussed. The minutes of the meeting are available on the HIAL web site at https://www.hial.co.uk/downloads/file/295/hial-board-minutes-february-2021 .

The Scottish Government greatly values the work of Scotland’s offshore workers and have been in regular discussions with Oil and Gas UK throughout this pandemic. Scottish Government appreciates and values the work that offshore workers are doing in what can be difficult circumstances.

The order in which people will be offered the vaccine in Scotland is based on advice from the Joint Committee on Vaccination and Immunisation (JCVI). The Scottish Government is vaccinating in line JCVI priority as quickly as supply allows us to do so.

Decisions to prioritise one population group over another are not taken lightly, nor are they straightforward. That is why prioritisation decisions are guided by the independent expert advice from the JCVI. Currently there is a mass vaccination centre open at the P&J Live at TECA in Aberdeen. If any offshore worker cannot attend their appointment, they should contact the helpline to reschedule.

We recognise the importance to sustainable aquaculture of high fish health and welfare standards. We will therefore consider the EU’s Strategic Guidelines on Sustainable Aquaculture alongside other sources of advice such as the UK Animal Welfare Committee, the British Veterinary Association and the Scottish Animal Welfare Commission.

The contracts for the Central and South lots of the Reaching 100% (R100) programme were signed on 16 December 2019. Contract signature for the North lot was completed on 11 December 2020, following dismissal of a legal challenge which had delayed contract signature.

As outlined in the response to S6W-00008 on 24 May 2021, the Scottish Government provided Openreach with a finalised speed and coverage template (or SCT) for the R100 North lot contract at the end of March 2021, which covers both the Highlands and the north east of Scotland. The remodelling exercise to finalise their coverage footprint is ongoing and will be subject to rigorous review through Scottish Government governance and assurance structures, and those of Building Digital UK (BDUK). The full picture across the R100 North lot contract area is expected to be available by Summer 2021.

The roll-out of R100 build in the North lot – and the associated survey work – will be completed in phases, and build plans will be reflected in our online checker at scotlandsuperfast.com.

All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The information requested is not held centrally. All Boards are currently offering a mix of online and face to face appointments in CAMHS. It is a matter for individual Health Boards and clinicians to determine how autism assessments are administered.

Current JCVIadvice does not cover vaccination in those under 18 years old, so far only 16 and 17 years olds in groups 1-9 are covered.

The Joint Committee on Vaccination and Immunisation (JCVI) advises that only those children at very high risk of exposure and serious outcomes, such as older children with severe neuro-disabilities that require residential care, should be offered vaccination with either the Pfizer-BioNTech or the AstraZeneca vaccine. We will continue to review our approach in line with JCVI advice.

Clinical trials are currently underway for vaccination of children and young people.

We will continue to engage with vaccine developers, and the JCVI so that if trials are successful we are ready to vaccinate younger age groups, if that is what the clinical and scientific evidence supports.